ANDA Abbreviated New Drug Application BY N.NARESH KUMAR m.pharm(cology) Definition of ANDA:  AN “abbreviated new drug application” (ANDA) is an application for a US…

1. Case study on MerckMade by- CharanjeetsinghEshanchhagotraJitendrasawan 2. Back ground:Merck has been one of the top pharmaceutical firm of the world.The firm is about…

1. Professional Development Lecture 4A career inIndustry vs. Academia Peter Rose [email_address] Feb 11, 2011 Professional Development Series 2. Agenda What differentiates…

Slide 11 INTENSIVE PATENT VALUATION Karl F. Jorda David Rines Professor of Intellectual Property Law & Industrial Innovation Director, Kenneth J. Germeshausen Center…

Slide 1Sustainable Medicine New Directions for Research David Servan-Schreiber, MD, Ph.D Clinical Professor of Psychiatry, University of Pittsburgh Lecturer, Faculté de…

1. Presented at Pharmacovigilance 2010, January 21-22, 2010Dr. Bhaswat S. ChakrabortySenior VP, R&D, Cadila Pharmaceuticals Jnauary 22, 2009 2. Risk Management andPharmacovigilance…

Anti-Fouling/Non-Fouling Surfaces Anti-Fouling/Non-Fouling Surfaces BT5011-July-Dec-2014 1 BT5011-July-Dec-2014 2 When is the non-specific adsoption undesirable? BT5011-July-Dec-2014…

âTo Market, To Marketâ or âFrom Test to Chest (Medicine Chest, that is)â A high-level overview of the clinical trial process in the development of brand pharmaceutical…

THE VALUATION OF PATENTS : A review of patent valuation methods with consideration of option based methods and the potential for further research Robert Pitkethly The Said…

Slide 1Fordham IP Conference 2011 Supplementary Protection Certificates Recap and Current Status 29 April 2011 Brian Cordery Bristows London Slide 2 Agenda Reminder of some…